-
平臺(tái)編號(hào)：bio-68929
-
國際編號(hào)：HB-319?
-
細(xì)胞信息： LYK-16
-
規(guī)格：frozen
-
用途：ATCC原裝細(xì)胞
-
服務(wù)費(fèi)用：
加載中…… - 訂購
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
LYK-16
ATCC Number：HB-319?
是否是腫瘤細(xì)胞：0
物種來源：大鼠
數(shù)量：大量
運(yùn)輸方式：凍存運(yùn)輸
細(xì)胞形態(tài)：淋巴樣
免疫類型：IgG2a
生長狀態(tài)：懸浮生長
規(guī)格：0.5mg Designations: LYK-16
Depositors: ?KS Hathcock, Y Yamashita
Isotype: IgG2a
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Rattus norvegicus (B cell); Mus musculus (myeloma) deposited as rat (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against a mouse CD44 determinant dependent upon posttranslational modification (specific exon unknown)
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments:Animals were immunized with a fusion protein corresponding to the products of CD44 variable exons V5 through V10.
Spleen cells were fused with Sp2/0-Ag14 mouse myeloma cells.
The antibody is specific for a determinant that is apparently dependent upon posttranslational modification of CD44.
The specific exon coding for the determinant is not known.
Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, 1.0 mM sodium pyruvate and supplemented with:0.05 mM 2-mercaptoethanol1% Origen Hybridoma Cloning Factor10% fetal bovine serum
Temperature: 37.0°C
Subculturing: Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
Maintain cultures at cell concentrations between 1 X 10(5) and 8 X 10(5) viable cells/ml.
Preservation: Culture medium, 95%; DMSO, 5%
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020
References: 38505: Yamashita Y, et al. Tissue-specific and growth-regulated expression of CD44 variable exon determinants in the mouse. Cell. Immunol. 176: 22-33, 1997. PubMed: 9070314
是否是腫瘤細(xì)胞：0
物種來源：大鼠
數(shù)量：大量
運(yùn)輸方式：凍存運(yùn)輸
細(xì)胞形態(tài)：淋巴樣
免疫類型：IgG2a
生長狀態(tài)：懸浮生長
規(guī)格：0.5mg Designations: LYK-16
Depositors: ?KS Hathcock, Y Yamashita
Isotype: IgG2a
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Rattus norvegicus (B cell); Mus musculus (myeloma) deposited as rat (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against a mouse CD44 determinant dependent upon posttranslational modification (specific exon unknown)
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments:Animals were immunized with a fusion protein corresponding to the products of CD44 variable exons V5 through V10.
Spleen cells were fused with Sp2/0-Ag14 mouse myeloma cells.
The antibody is specific for a determinant that is apparently dependent upon posttranslational modification of CD44.
The specific exon coding for the determinant is not known.
Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, 1.0 mM sodium pyruvate and supplemented with:0.05 mM 2-mercaptoethanol1% Origen Hybridoma Cloning Factor10% fetal bovine serum
Temperature: 37.0°C
Subculturing: Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
Maintain cultures at cell concentrations between 1 X 10(5) and 8 X 10(5) viable cells/ml.
Preservation: Culture medium, 95%; DMSO, 5%
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020
References: 38505: Yamashita Y, et al. Tissue-specific and growth-regulated expression of CD44 variable exon determinants in the mouse. Cell. Immunol. 176: 22-33, 1997. PubMed: 9070314
